Trial reportExperimental and clinical psychopharmacology2025
Polysubstance use patterns and risk behaviors among people with cocaine use disorder.
Trial report in Experimental and clinical psychopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Repeated measures latent class analysis identifies unique daily cocaine-use patterns and associated clinical characteristics: A timeline followback-based analytic approach.Drug and alcohol dependence reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Both laboratory model and real-world study data suggest that cocaine use is associated with impulsivity and risk-taking. Further, many people who use cocaine report polysubstance use; however, there is a lack of research investigating associations between and among impulsivity, risk-taking, and polysubstance use. Polysubstance use involving cannabis is especially relevant given its use by over half of Americans who use cocaine. No work to date has examined the potential relations between concurrent use of cannabis and cocaine and outcomes of impulsivity and risk-taking. The present study compared participants whose urine was positive for cocaine, positive for cocaine and cannabis, and negative for cocaine and cannabis during an initial pretreatment baseline visit for 122 participants prior to enrollment in a randomized clinical trial for cocaine use disorder. Data suggest participants who co-used cocaine and cannabis were likely to use more cocaine and other substances (e.g., alcohol, other drugs) and self-report risky sexual behavior. Participants who abstained from cocaine and cannabis prior to the baseline appointment gambled at greater rates in a gambling task. Groups did not differ with respect to self-reported impulsivity. Co-use of cocaine and cannabis among those with cocaine use disorder is associated with increased drug use but may have limited association with self-reported impulsivity. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.